BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 22629598)

  • 21. Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach.
    Fei Y; Kostewicz ES; Sheu MT; Dressman JB
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1274-84. PubMed ID: 23500116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of presence of excipients in drug analysis in fed-state gastric biorelevant media.
    Baxevanis F; Kuiper J; Fotaki N
    Eur J Pharm Biopharm; 2018 Oct; 131():178-188. PubMed ID: 30110669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of reduced gastric acid secretion on dissolution of salts of weak bases in the fasted upper gastrointestinal lumen: Data in biorelevant media and in human aspirates.
    Litou C; Vertzoni M; Xu W; Kesisoglou F; Reppas C
    Eur J Pharm Biopharm; 2017 Jun; 115():94-101. PubMed ID: 28214603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biorelevant dissolution testing of a weak base: Interlaboratory reproducibility and investigation of parameters controlling in vitro precipitation.
    Berben P; Ashworth L; Beato S; Bevernage J; Bruel JL; Butler J; Dressman J; Schäfer K; Hutchins P; Klumpp L; Mann J; Nicolai J; Ojala K; Patel S; Powell S; Rosenblatt K; Tomaszewska I; Williams J; Augustijns P
    Eur J Pharm Biopharm; 2019 Jul; 140():141-148. PubMed ID: 31051249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A modified physiological BCS for prediction of intestinal absorption in drug discovery.
    Zaki NM; Artursson P; Bergström CA
    Mol Pharm; 2010 Oct; 7(5):1478-87. PubMed ID: 20734997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug supersaturation in simulated and human intestinal fluids representing different nutritional states.
    Bevernage J; Brouwers J; Clarysse S; Vertzoni M; Tack J; Annaert P; Augustijns P
    J Pharm Sci; 2010 Nov; 99(11):4525-34. PubMed ID: 20845451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of biorelevant media for assessment of a poorly soluble weakly basic drug in the form of liquisolid compacts: in vitro and in vivo study.
    Badawy MA; Kamel AO; Sammour OA
    Drug Deliv; 2016; 23(3):818-27. PubMed ID: 24892630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intestinal drug solubility estimation based on simulated intestinal fluids: comparison with solubility in human intestinal fluids.
    Clarysse S; Brouwers J; Tack J; Annaert P; Augustijns P
    Eur J Pharm Sci; 2011 Jul; 43(4):260-9. PubMed ID: 21570465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biopharmaceutical classification of poorly soluble drugs with respect to "enabling formulations".
    Buckley ST; Frank KJ; Fricker G; Brandl M
    Eur J Pharm Sci; 2013 Sep; 50(1):8-16. PubMed ID: 23583787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting pharmacokinetic food effects using biorelevant solubility media and physiologically based modelling.
    Jones HM; Parrott N; Ohlenbusch G; Lavé T
    Clin Pharmacokinet; 2006; 45(12):1213-26. PubMed ID: 17112297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3.
    Franek F; Holm P; Larsen F; Steffansen B
    Int J Pharm; 2014 Jan; 461(1-2):419-26. PubMed ID: 24342711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fasted and fed state human duodenal fluids: Characterization, drug solubility, and comparison to simulated fluids and with human bioavailability.
    Dahlgren D; Venczel M; Ridoux JP; Skjöld C; Müllertz A; Holm R; Augustijns P; Hellström PM; Lennernäs H
    Eur J Pharm Biopharm; 2021 Jun; 163():240-251. PubMed ID: 33872761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In Vivo Predictive Dissolution (IPD) and Biopharmaceutical Modeling and Simulation: Future Use of Modern Approaches and Methodologies in a Regulatory Context.
    Lennernäs H; Lindahl A; Van Peer A; Ollier C; Flanagan T; Lionberger R; Nordmark A; Yamashita S; Yu L; Amidon GL; Fischer V; Sjögren E; Zane P; McAllister M; Abrahamsson B
    Mol Pharm; 2017 Apr; 14(4):1307-1314. PubMed ID: 28195732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Designing a dynamic dissolution method: a review of instrumental options and corresponding physiology of stomach and small intestine.
    Culen M; Rezacova A; Jampilek J; Dohnal J
    J Pharm Sci; 2013 Sep; 102(9):2995-3017. PubMed ID: 23494815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of drug precipitation of solubility-enhancing liquid formulations using milligram quantities of a new molecular entity (NME).
    Dai WG; Dong LC; Shi X; Nguyen J; Evans J; Xu Y; Creasey AA
    J Pharm Sci; 2007 Nov; 96(11):2957-69. PubMed ID: 17705287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Canine intestinal contents vs. simulated media for the assessment of solubility of two weak bases in the human small intestinal contents.
    Kalantzi L; Persson E; Polentarutti B; Abrahamsson B; Goumas K; Dressman JB; Reppas C
    Pharm Res; 2006 Jun; 23(6):1373-81. PubMed ID: 16715357
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humans.
    Shono Y; Jantratid E; Kesisoglou F; Reppas C; Dressman JB
    Eur J Pharm Biopharm; 2010 Sep; 76(1):95-104. PubMed ID: 20576487
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insight into the Development of Dissolution Media for BCS Class II Drugs: A Review from Quality Control and Prediction of In Vivo Performance Perspectives.
    Wu C; Liu Y; He Z; Sun J
    Curr Drug Deliv; 2016; 13(7):1004-1020. PubMed ID: 26725724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A review of drug solubility in human intestinal fluids: implications for the prediction of oral absorption.
    Augustijns P; Wuyts B; Hens B; Annaert P; Butler J; Brouwers J
    Eur J Pharm Sci; 2014 Jun; 57():322-32. PubMed ID: 23994640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficiency of single pharmaceutical surfactants to mimic intestinal biorelevant media solubilization and dissolution of etravirine: Comparison of intrinsic and film dissolution models.
    Oktay AN; Polli JE
    Eur J Pharm Sci; 2024 May; 196():106746. PubMed ID: 38499112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.